0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The World in Medicine |

Clues to Bipolar Disorder

Joan Stephenson, PhD
JAMA. 2008;300(11):1291. doi:10.1001/jama.300.11.1291-d.
Text Size: A A A
Published online

Extract

Researchers from the United States, the United Kingdom, and Australia have linked variants in 2 genes with an increased risk of bipolar disorder (Ferreira MA et al. Nat Genet. doi:10.1038 /ng.209 [published online ahead of print August 17, 2008]). Both genes encode proteins that play roles in ion channels in nerve cells and affect the excitability of neurons.

The genome-wide association study, which tested 1.8 million variants in 4387 individuals with bipolar disorder and 6209 controls, found the strongest evidence for increased risk of the disorder for variants in 2 genes involved in the balance of sodium and calcium in cells: ANK3, which encodes a protein (ankyrin G) reported to regulate the assembly of sodium channels, and CACNA1C, which encodes a calcium channel subunit. Previous research in mice by some members of the research team had demonstrated that the drug most commonly used to treat bipolar disorder, lithium (which affects the way sodium moves through ion channels), reduces the expression of both ANK3 and subunits of the calcium channel.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();